Brief: Argenica Therapeutics Says Positive Preclincal Data On Efficacy Of Arg-007 In New Indication
30/03/2022 02:25
March 30 (Reuters) - Argenica Therapeutics Ltd AGN.AX :
* ARGENICA THERAPEUTICS LTD - POSITIVE PRECLINCAL DATA ON
EFFICACY
OF ARG-007 IN NEW INDICATION - GLOBAL CEREBRAL ISCHAEMIA
* ARGENICA THERAPEUTICS LTD - RESULTS FROM THE STUDY WILL
FURTHER
SUPPORT EFFICACY DATA PACKAGE FOR PHASE 1 CLINICAL TRIAL.
Source text for Eikon: ID:nASX5n7DWs
Further company coverage: AGN.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argenica Therapeutics
See all newsBrief: Argenica Therapeutics Says IND Application Advanced With Successful Completion Of Assay
Brief: Argenica Therapeutics Says Dianne Angus To Step Down As Non-Executive Chair
Australia's Argenica Therapeutics jumps on meeting FDA condition
Brief: Argenica Therapeutics Seeks Trading Halt
Brief: Argenica Therapeutics Gets Non-Dilutive Funding Up To A Total Of A$1.5M